Promis Neurosciences Inc.
SEC CIK 1374339 · PMN · last insider filing 2026-05-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Wyman William W | Director | filed 2022 - 2026 |
| Warma Neil K | Director · Chief Executive Officer | filed 2022 - 2026 |
| Mandel-Brehm Josh | Director | filed 2022 - 2026 |
| Cashman Neil | Director · Chief Scientific Officer | filed 2022 - 2026 |
| Shafmaster Madge K. | Director | filed 2022 - 2026 |
| Williams Eugene | Director · Chairman and CEO | filed 2022 - 2026 |
| Alex Slanix Paul | Director | filed 2025 - 2026 |
| Kirwin Patrick D. | Director | filed 2022 - 2026 |
| Malenfant Gavin T. | Director · Chief Operating Officer | filed 2022 - 2023 |
| Farfel Gail M | Director · Chief Executive Officer | filed 2022 - 2023 |
| Gregory Richard J. | Director | filed 2022 - 2022 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Milbury Max A. | Principal Accounting Officer | filed 2022 - 2026 |
| Kaplan Johanne | Chief Development Officer | filed 2023 - 2026 |
| Altstiel Larry Douglas | Chief Medical Officer | filed 2022 - 2025 |
| Geffken Daniel E. | Chief Financial Officer | filed 2022 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.